Ira Duarte

Insider Reports History

Location
1255 Crescent Green Drive, Suite 250, Cary, NC
Signature
/s/Kathryn Lester Attorney-in-fact for Ira Duarte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ira Duarte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Restricted Stock Units 152K $494K $2.64 Oct 31, 2025 Direct
TerrAscend Corp. Director Common Shares 658K $257K $0.39 Jun 24, 2025 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Common Stock 180K $227K $1.26 Oct 31, 2025 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Employee Stock Option (Right to Buy) 374K Jan 31, 2025 Direct

Insider Reports Filed by Ira Duarte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 31, 2025 2 $0 4 Nov 4, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 19, 2025 2 $0 4 Oct 21, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2025 2 $0 4 Aug 4, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2025 2 $0 4 Jul 22, 2025 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Jun 24, 2025 1 $0 4 Jun 25, 2025 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 16, 2025 2 $0 4 Jun 17, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 30, 2025 2 $0 4 May 2, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 19, 2025 2 $0 4 Apr 22, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 31, 2025 2 $0 4 Feb 4, 2025 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2025 2 $0 4 Jan 22, 2025 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Dec 31, 2024 1 -$46.6K 4 Jan 3, 2025 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 19, 2024 2 $0 4 Oct 21, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2024 2 $0 4 Jul 22, 2024 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 16, 2024 2 $0 4 Jun 17, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 19, 2024 3 -$2.96K 4 Apr 19, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2024 2 $0 4 Jan 19, 2024 EVP, Chief Financial Officer
HRTX HERON THERAPEUTICS, INC. /DE/ Nov 16, 2023 1 $75.6K 4 Nov 17, 2023 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 16, 2023 0 $0 3 Jun 23, 2023 EVP, Chief Financial Officer
TSNDF TerrAscend Corp. Dec 1, 2022 0 $0 3 Dec 9, 2022 Director